BK-6-MAPB

BK-6-MAPB
Clinical data
Other names	BK-6-MAPB; NM-PrBF6; 6-[2-(Methylamino)propanoyl]benzofuran
Routes of; administration	Oral
Drug class	Serotonin releasing agent; Serotonin 5-HT1B receptor agonist; Entactogen
ATC code	None;
Identifiers
	IUPAC name 1-(1-benzofuran-6-yl)-2-(methylamino)propan-1-one;
PubChem CID	163982955;
ChemSpider	129893181;
ChEMBL	ChEMBL5397645;
Chemical and physical data
Formula	C12H13NO2
Molar mass	203.241 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CNC(C(=O)c1ccc2c(c1)occ2)C;
	InChI InChI=1S/C12H13NO2/c1-8(13-2)12(14)10-4-3-9-5-6-15-11(9)7-10/h3-8,13H,1-2H3; Key:SZYQYVVTRVJIPK-UHFFFAOYSA-N;

βk-6-MAPB, or BK-6-MAPB, also known as NM-PrBF6 or as 6-[2-(methylamino)propanoyl]benzofuran, is a putative entactogen of the benzofuran and cathinone groups.^[1]^[2] It was patented by Matthew Baggott and Tactogen.^[1]^[3]^[4] The drug is known to act as a potent serotonin releasing agent.^[1]^[5] In addition, unlike MDMA, it is a potent serotonin 5-HT_1B receptor agonist.^[5] βk-6-MAPB was encountered as a novel designer drug online in 2019.^[2]

Other namesBK-6-MAPB; NM-PrBF6; 6-[2-(Methylamino)propanoyl]benzofuran

Quick facts Clinical data, Other names ...

Close

See also

Clinical data

Other names	BK-6-MAPB; NM-PrBF6; 6-[2-(Methylamino)propanoyl]benzofuran
Routes of administration	Oral
Drug class	Serotonin releasing agent; Serotonin 5-HT_1B receptor agonist; Entactogen
ATC code	None
Identifiers
IUPAC name 1-(1-benzofuran-6-yl)-2-(methylamino)propan-1-one
PubChem CID	163982955
ChemSpider	129893181
ChEMBL	ChEMBL5397645
Chemical and physical data
Formula	C₁₂H₁₃NO₂
Molar mass	203.241 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CNC(C(=O)c1ccc2c(c1)occ2)C
InChI InChI=1S/C12H13NO2/c1-8(13-2)12(14)10-4-3-9-5-6-15-11(9)7-10/h3-8,13H,1-2H3 Key:SZYQYVVTRVJIPK-UHFFFAOYSA-N